NPI: 1902836943 · SANFORD, NC 27330 · General Acute Care Hospital · NPI assigned 07/04/2006
Authorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWRENCE, CHARLOTTE (SECRETARY) |
| NPI Enumeration Date | 07/04/2006 |
Other providers sharing the same authorized official: LAWRENCE, CHARLOTTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 35,884 | $1.36M |
| 2019 | 39,611 | $1.41M |
| 2020 | 22,501 | $937K |
| 2021 | 27,162 | $1.34M |
| 2022 | 31,349 | $2.07M |
| 2023 | 39,954 | $2.10M |
| 2024 | 42,949 | $2.77M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 32,487 | 28,079 | $3.76M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 19,919 | 16,608 | $3.41M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,074 | 3,279 | $861K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7,196 | 6,335 | $523K |
| 41899 | Unlisted procedure, dentoalveolar structures | 407 | 380 | $466K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 8,760 | 6,971 | $268K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,906 | 2,434 | $236K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,605 | 4,317 | $188K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7,372 | 5,887 | $187K |
| 71045 | Radiologic examination, chest; single view | 4,497 | 3,779 | $166K |
| 80053 | Comprehensive metabolic panel | 18,167 | 14,905 | $147K |
| 87400 | 6,329 | 4,349 | $147K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,646 | 604 | $138K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19,693 | 16,098 | $132K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 645 | 549 | $112K |
| 70450 | Computed tomography, head or brain; without contrast material | 839 | 676 | $98K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6,091 | 5,063 | $79K |
| 71046 | Radiologic examination, chest; 2 views | 1,875 | 1,566 | $78K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 189 | 152 | $75K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,351 | 2,675 | $73K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,335 | 1,983 | $68K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2,623 | 2,153 | $66K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,954 | 3,249 | $65K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 879 | 693 | $65K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,120 | 1,072 | $64K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,039 | 2,429 | $55K |
| 81001 | 17,785 | 14,890 | $54K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2,453 | 1,348 | $52K |
| 36415 | Collection of venous blood by venipuncture | 17,442 | 14,043 | $37K |
| 81025 | 4,430 | 3,750 | $33K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,943 | 1,633 | $28K |
| 84484 | 3,682 | 2,659 | $26K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,047 | 996 | $24K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 607 | 358 | $21K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,858 | 3,298 | $17K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 431 | 362 | $16K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 570 | 481 | $15K |
| 84703 | 1,782 | 1,627 | $13K | |
| 83690 | 2,095 | 1,691 | $12K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 408 | 323 | $10K |
| 87420 | 609 | 454 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,195 | 951 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,036 | 894 | $8K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,350 | 1,182 | $7K |
| 83735 | 1,122 | 935 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 321 | 241 | $5K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 2,312 | 1,503 | $5K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 13 | 12 | $4K |
| 84702 | 331 | 268 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 140 | 122 | $3K |
| G0378 | Hospital observation service, per hour | 54 | 37 | $3K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 376 | 175 | $3K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 184 | 82 | $3K |
| 82550 | 519 | 400 | $2K | |
| 85730 | 432 | 365 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 72 | 69 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 72 | 69 | $2K |
| 87430 | 100 | 99 | $1K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 139 | 122 | $1K |
| 85610 | 453 | 380 | $1K | |
| 85027 | 248 | 186 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 332 | 309 | $1K |
| 82553 | 180 | 135 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 27 | 26 | $1K |
| J7050 | Infusion, normal saline solution, 250 cc | 109 | 92 | $1K |
| A9150 | Non-prescription drugs | 1,021 | 955 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 60 | 52 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 18 | 12 | $942.85 |
| 94664 | 61 | 52 | $848.65 | |
| 83605 | 127 | 81 | $776.04 | |
| 80076 | 147 | 109 | $740.08 | |
| J3490 | Unclassified drugs | 395 | 335 | $732.35 |
| J2704 | Injection, propofol, 10 mg | 116 | 109 | $727.14 |
| A6197 | Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | 162 | 52 | $580.58 |
| 87210 | 134 | 121 | $566.66 | |
| 87081 | 79 | 79 | $535.12 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 173 | 160 | $439.50 |
| 83880 | 15 | 12 | $320.51 | |
| 74018 | 13 | 12 | $283.36 | |
| 84100 | 69 | 55 | $254.06 | |
| 80305 | 26 | 25 | $233.57 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 247 | 213 | $215.93 |
| 82248 | 49 | 44 | $208.21 | |
| A4217 | Sterile water/saline, 500 ml | 63 | 62 | $112.50 |
| 85379 | 16 | 13 | $101.83 | |
| 87070 | 15 | 12 | $63.78 | |
| 82948 | 19 | 15 | $39.45 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 26 | 25 | $21.60 |
| 82962 | 25 | 13 | $20.44 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 77 | 71 | $0.00 |